Clinical Trial Update: Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in children aged 6-11 comparing an investigational nasal aerosol to placebo for seasonal allergic rhinitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Investigational nasal aerosol

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Seasonal Allergic Rhinitis, SAR | Phase 3 | Status: COMPLETED | Results posted: 2015-02-20